Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025)
Entera Bio (ENTX) recorded quarterly Asset Utilization Ratio of 0.0 in Q4 2025, down 62.4% on a QoQ basis from 0.01 in Q3 2025, and down 88.1% year-over-year from 0.02 in Q4 2024.
Entera Bio (ENTX) Asset Utilization Ratio (2022 - 2025) Analysis & Trends
Entera Bio has disclosed Asset Utilization Ratio across 4 years of filings, most recently posting 0.0 for Q4 2025.
- Quarterly Asset Utilization Ratio fell 88.1% year-over-year to 0.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0 (down 88.1% YoY) and the FY2025 annual result came in at 0.0, down 80.66% from the prior year.
- Asset Utilization Ratio fell to 0.0 in Q4 2025, from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.02 in Q4 2024 and troughed at 0.0 in Q3 2023.
- A 4-year average of 0.01 and a median of 0.01 in 2025 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio tumbled 91.05% — and 2024, when it surged 656.23%.
- Tracing ENTX's Asset Utilization Ratio over 4 years: stood at 0.01 in 2022, then tumbled by 84.24% to 0.0 in 2023, then surged by 1334.66% to 0.02 in 2024, then tumbled by 88.1% to 0.0 in 2025.
- Business Quant data shows ENTX's Asset Utilization Ratio at 0.0 in Q4 2025, 0.01 in Q3 2025, and 0.01 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 0.55 |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Entera Bio | 57.79 Mn | 53.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.01 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.02 |